FDA Drug Recalls

Recalls / Class II

Class IID-0374-2019

Product

0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) a.) 1 mL in 3 mL BD Syringe, 10 per carton, b.) 0.9% Buffered Lidocaine HCl (buffered in 8.4% Sodium Bicarbonate) 5 mL in 5 mL BD Syringe, 10 per carton Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478.

Affected lot / code info
Service Code 2K2466 and 2K2470 183320004S, 183330008S, 183340002S, 183340003S, 183300004S, 183310007S, 183370041S, 183310043S, 183370042S, 183320003S, 183380007S, 183250013S, 183250014S, 183320005S, 183330009S, 183370007S, 183390044S, 183400006S, 183410003S.

Why it was recalled

Subpotent

Recalling firm

Firm
PharMEDium Services, LLC.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
913 N Davis Ave, Cleveland, Mississippi 38732-2106

Distribution

Quantity
7,711 syringes
Distribution pattern
Product was distributed throughout the United States.

Timeline

Recall initiated
2019-01-02
FDA classified
2019-01-14
Posted by FDA
2019-01-16
Terminated
2020-05-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0374-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.